NAFLD-Exo administration to cells resulted in a significantly (P < 0.001) increased expression of RIP-1 in the cytoplasm of Hepa-RG cells (Fig. 4A, B), while phospho-RIP-1, was strongly expressed in the nuclei (Fig. 4C). The gene discussed is RIPK1; the disease is metabolic dysfunction-associated steatotic liver disease.